Postoperative Dumping Syndrome

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Postoperative Dumping Syndrome trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT07440706

Continuous Glucose Monitoring With iCan i3 in Post-Bariatric Patients With Late Dumping Syndrome

Late dumping syndrome is a common complication following Roux-en-Y gastric bypass, characterized by postprandial hypoglycemia with significant impact on patient…

Brazil60 participantsStarted 2025-10-15

Treatment: Can i3 Continuous Glucose Monitoring System

RecruitingNot Applicable

NCT04522193

Dumping Syndrome and Esophageal Atresia

Dumping syndrome (DS) is frequent in oesophageal atresia (29%). In causing hypoglycaemia, it can be dangerous for neonates. Mechanisms of DS are actually partia…

France15 participantsStarted 2024-02-23

Treatment: Glycemic Holter, gastric emptying scintigraphy

All recent trials (17 shown)

Active — Not RecruitingNot Applicable

NCT07263269

Comparing Dumping Symptoms and Quality of Life 6 Months After Sleeve Gastrectomy With or Without Transit Bipartition in…

This clinical study aims to compare two types of bariatric (weight loss) surgery used to treat obesity: sleeve gastrectomy alone and sleeve gastrectomy with tra…

Egypt200 participantsStarted 2024-04-06

Treatment: Sleeve Gastrectomy, Sleeve Gastrectomy with Transit Bipartition

CompletedPhase 4

NCT01794793

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

The purpose of this study is to allow continued use of pasireotide in patients who are on pasireotide treatment in a Novartis-sponsored study and are benefiting…

United States337 participantsStarted 2013-06-10

Treatment: Pasireotide, Cabergoline

Postoperative Dumping Syndrome

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Continuous Glucose Monitoring With iCan i3 in Post-Bariatric Patients With Late Dumping Syndrome

Dumping Syndrome and Esophageal Atresia

All recent trials (17 shown)

Comparing Dumping Symptoms and Quality of Life 6 Months After Sleeve Gastrectomy With or Without Transit Bipartition in…

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Continuous Glucose Monitoring With iCan i3 in Post-Bariatric Patients With Late Dumping Syndrome

Dumping Syndrome and Esophageal Atresia

All recent trials (17 shown)

Comparing Dumping Symptoms and Quality of Life 6 Months After Sleeve Gastrectomy With or Without Transit Bipartition in…

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Fat Supplementation on Dumping Syndrome Related Symptoms After Gastric Surgery

Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass

SOMATULINE Autogel 90 mg IN DUMPING SYNDROME

Fat Supplementation on Dumping Syndrome Associated Symptoms

MAgnetic Gastrointestinal Universal Septotome: a Safety and Feasibility Study (MAGUS)

Gastrointestinal Nutrient Transit and Enteroendocrine Function After Upper Gastrointestinal Surgery

Impact of an Educational Personalized Clinical Support Device Preventive and a Referent Nurse in Surgery for Obesity

Gastrectomy, Eating Behaviour and GLP-1

Dumping Syndrome After Operation of Esophageal Atresia Type III

Metabolic Consequences of Gastrointestinal Surgery

Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome

Study to Assess Safety and Efficacy of sc Pasireotide in Patients With Dumping Syndrome

Treatment of the Dumping Syndrome With Lanreotide Autogel®